The stock of Immunotec Inc (CVE:IMM) gapped up by $0.015 today and has $0.79 target or 98.00% above today’s $0.40 share price. The 7 months technical chart setup indicates low risk for the $26.12M company. The gap was reported on Nov, 4 by Barchart.com. If the $0.79 price target is reached, the company will be worth $25.60M more.
Gaps up are useful for using as a support level and to some extent as a tradeable event. If investors already hold the stock and experience a price gap up, then its usually a good idea to hold the stock for a stronger up move. Back-tests of these patterns indicate that two-thirds of the times the stock performance improves after the gap. The area gaps close 89% of the time, the breakaway gaps, 2%, the continuation gaps 4% and the exhaustion gaps 61%. About 27,000 shares traded hands or 474.35% up from the average. Immunotec Inc (CVE:IMM) has risen 6.00% since October 5, 2016 and is uptrending. It has outperformed by 4.91% the S&P500.
More notable recent Immunotec Inc (CVE:IMM) news were published by: Marketwired.com which released: “Immunotec Inc.: Immunocal® Used in Novel Prehabilitation Study” on October 14, 2014, also Marketwired.com with their article: “Sigrid Beer Purchases 500000 Common Shares of Immunotec Inc. from Robert M …” published on March 28, 2014, Marketwired.com published: “Immunotec Announces Executive Promotions” on February 29, 2016. More interesting news about Immunotec Inc (CVE:IMM) were released by: Marketwired.com and their article: “Immunotec Reports 2014 Year-End Results” published on January 26, 2015 as well as Marketwatch.com‘s news article titled: “Immunotec Reports 2015 Year-End Results” with publication date: January 28, 2016.
Immunotec Inc. is a Canada-based company that develops, makes, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States and Mexico. The company has a market cap of $26.12 million. The Firm also subcontracts certain distribution logistics and manufacturing capacity activities in the United States, Europe and Mexico to support its activities. It has a 8.57 P/E ratio. It makes and sells natural health products, dietary supplements and cosmetics, and sells them under a network marketing business model.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.